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Objectives. We hypothesized that angiotensin-converting en- 
zyme inhibitors would limit dysfunction in the first 8 weeks after 
transmural infarction in adjacent noninfarcted regions, as well as 
attenuate left ventricular remodeling. 
Background. Angiotensin-converting enzyme inhibition limits 
ventricular dilation and hypertrophy and improves survival after 
anterior infarction, but its effect on regional function during 
remodeling is not well characterized. 
Methods. Thirteen sheep underwent coronary ligation to create 
an anteroapical infarction. At postinfarction day 2, eight sheep 
were randomized to therapy with the angiotensin-converting en- 
zyme inhibitor ramipril, and five sheep received no therapy. 
Animals were studied with magnetic resonance myocardial tag- 
ging before and 8 weeks after infarction. Left ventricular volume, 
mass and ejection fraction were measured, as were changes in 
percent circumferential shortening within the subendocardium 
and subepicardium of infarcted and noninfarcted myocardium, 
both adjacent to and remote from the infarction. 
Results. Angiotensin-converting enzyme inhibition limited the 
increase in end-diastolic volume from a mean (+-SD) of +1.5 -+ 
0.7 ml/kg in control animals to +0.5 + 0.8 ml/kg in the treated 
group (p < 0.04). Segmental function within infarcted and remote 
noninfarcted tissue did not differ between groups. However, 
angiotensin-converting enzyme inhibition limited the decline in 
function in the adjacent noninfarcted region 8 weeks after infarc- 
tion. Percent circumferential shortening in the subendocardium 
decreased by -13 -+ 5% in the control group compared with -5  -+ 
5% in the treated group (p < 0.03). 
Conclusions. In concert with a reduction in left ventricular 
remodeling after anterior infarction, angiotensin-converting en- 
zyme inhibition limits the decline in function in the adjacent 
noninfarcted region. Dysfunction in adjacent noninfarcted re- 
gions may be an important determinant of left ventricular remod- 
eling after infarction. 
(J Am Coil Cardiol 1996;27:211-7) 
In response to myocardial loss from transmural nterior myo- 
cardial infarction, the left ventricle changes in size and shape 
(1-4). Left ventricular enlargement after infarction, regardless 
of location, is predictive of late heart failure and mortality 
(5,6). Early in the postinfarction period, the infarcted area 
expands (7). In the next several weeks after large anterior 
infarctions, hearts undergo progressive dilation and eccentric 
hypertrophy associated with lengthening ofnoninfarcted seg- 
ments (8,9). 
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With the advent of magnetic resonance tissue tagging 
(10,11), regional intramural mechanical function within finite 
areas of rnyocardium can be assessed ina regional, transmural 
and temporal manner without invasive marker implantation 
(9,12,13). Breath-hold tagging has increased the speed of data 
acquisition (15 s vs. 5 rain on average for a short-axis slice), 
decreasing the time necessary to perform a complete study 
(14). Using magnetic resonance tagging, we previously showed 
(9) that global changes in ventricular architecture are associ- 
ated with regional differences in function between onin- 
farcted myocardium adjacent to and remote from transmural 
anteroapical infarction. Function in the adjacent noninfarcted 
region decreases markedly early after infarction but improves 
during infarct healing phase between 1 and 8 weeks after 
infarction. However, differences in function between adjacent 
and remote noninfarcted myocardium present at 1 week after 
infarction persist up to 6 months after myocardial infarction. 
Inhibition of angiotensin-converting enzyme improved 
pressure-volume relations (15) and survival (16) in a rat model 
of moderate-sized myocardial infarction. Various angiotensin- 
converting enzyme inhibitors have been demonstrated to re- 
duce global ventricular remodeling in the canine model of 
infarction (17,18). Angiotensin-converting e zyme inhibition 
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has also been demonstrated to reduce short- and long-term 
mortality after myocardial infarction in humans (19-21). The 
limitation in ventricular dilation by angiotensin-converting 
enzyme inhibitors is an important factor in improved survival. 
Captopril therapy in the Survival and Ventricular Enlargement 
(SAVE) study (22) was associated with attenuation of this 
enlargement and an improvement in clinical outcome. The 
effect of angiotensin-converting e zyme inhibition on regional 
mechanical function within noninfarcted myocardium remains 
unclear. 
The present study was undertaken to assess the effect of 
angiotensin-converting e zyme inhibition on regional function 
within noninfarcted myocardium during the early phases of left 
ventricular emodeling using magnetic resonance tissue tag- 
ging in an ovine model of myocardial infarction. We hypothe- 
sized that angiotensin-converting enzyme inhibitors would 
limit the adjacent noninfarcted regional dysfunction known to 
occur in the first 8 weeks after infarction, in parallel with 
attenuation of left ventricular remodeling. 
Methods 
Experimental protocol. In 15 Q fever-negative Dorsett 
sheep, a left thoracotomy was performed as previously de- 
scribed (9,23), with ligation of the left anterior descending 
coronary artery and its second diagonal branch to create a 
moderate-sized anteroapical infarction. Of 15 sheep, 13 com- 
pleted the protocol, 1 died intraoperatively from ventricular 
fibrillation, and 1 control animal developed a positive nzyme- 
linked immunosorbent assay (ELISA) test for Q fever and was 
killed at 4 weeks after infarction. All procedures followed were 
in accordance with the "Position of the American Heart 
Association on Research Animal Use" adopted by the Asso- 
ciation in November 1984 and the Institutional Animal Care 
and Use Committees at the University of Pennsylvania and the 
Allegheny-Singer Research Institute. 
At postinfarction day 2, the sheep were randomized to 
ramipril (10 mg orally each day) or no therapy, which was then 
continued aily throughout 8 weeks after infarction. Blood was 
drawn for measurement of trough serum angiotensin-converting 
enzyme levels at postinfarction day 2 (before randomization) and 
at 1, 4 and 8 weeks after infarction. Angiotensin-converting 
enzyme levels were measured by direct spectrophotometric assay 
(MetPath Laboratories). Weekly blood pressures were deter- 
mined using an automated pediatric blood pressure cuff in the left 
forelock of the standing animal. 
After the terminal imaging study, performed 8weeks after 
infarction, the sheep were killed under deep barbiturate anes- 
thesia with an intravenous bolus of potassium chloride. The 
left ventricle was filled with wet gauze, and the hearts were 
fixed in formalin for 48 h. The hearts were then sectioned 
transversely into 1.0-cm thick slices. Transparencies of the 
sectioned hearts were traced, with notation made of right 
ventricular insertions, papillary muscles and thinned infarcted 
segments. Wall thicknesses of infarcted segments and adjacent 
and remote noninfarcted segments were measured. Wall thick- 
ness in adjacent issue was taken as the average of three 
measurements made in tissue within 2 cm of the infarct border. 
The most basal slice was used to measure wall thickness in 
remote noninfarcted tissue as the average of three measure- 
ments around the left ventricular circumference. The clearly 
demarcated infarcted tissue was dissected free of noninfarcted 
tissue and weighed for measurement of infarct mass (percent 
of total left ventricular mass) from the postmortem specimen. 
Imaging protocol. Before the imaging sessions, all animals 
were premedicated intravenously with diazepam (1 rag), pen- 
icillin (22,000 U/kg) and gentamicin (3 mg/kg body weight). 
Intravenous guaifenesin (5%) and ketamine (500 rag) provided 
heavy sedation during imaging. Intubation, mechanical venti- 
lation, nasogastric suction and electrocardiographic (ECG) 
monitoring were performed. Pulmonary capillary wedge pres- 
sures were obtained by Swan-Ganz catheterization at both 
time points. 
To evaluate regional intramyocardial function, magnetic 
resonance tagging was performed in all animals before and 8 
weeks after infarction. The first eight sheep (three control, five 
treated) were studied by spin echo tagging using a body coil 
(9,12,13), which took up to 90 rain to obtain interleaved 
short-axis images. To accelerate image acquisition, the last five 
sheep (two control, three treated) were studied by rapid 
breath-hold gradient echo imaging with a surface coil (14), 
which allows imaging in multiple planes in -<45 rain. 
The initial imaging protocol before the tagging series was 
the same for all sheep. Each animal was placed in the right 
lateral decubitus position, and ECG gating was initiated. After 
scout images were obtained, the timing of end-systole was 
identified as the point of minimal eft ventricular cavity volume 
by a multiphase, single-slice, cine series at the base of the 
ventricle with frames obtained at 25-ms intervals. 
For spin echo tagging compound oblique short-axis images 
using the spatial modulation of magnetization pulse sequence 
and tag stripes 7 mm apart were then obtained, as previously 
described (9,12,13). Imaging variables were echo time 27 ms, 
repetition time equal to the RR interval, 5-mm thick slices, 
5-ram skips between slices, 24-cm field of view and a 256 × 128 
matrix yielding a final interpolated pixel size of 0.88 mm 2. To 
enhance myocardial signal and stripe persistence, flow com- 
pensation, a flip angle of 130 ° and one signal average were 
used. Multislice, multiphase, short-axis tagged spin echo im- 
ages were obtained from end-diastole to end-systole. Four to 
five slices spanning the entire left ventricle were imaged at four 
or five time instances with an intersequence d lay adjusted to 
ensure that the last image coincided with end-systole as 
defined by the cine series. A second set of images was 
subsequently obtained in the same manner but was interleaved 
with the previous eries by localizing the first slice 5 mm apical 
to the most basal slice of that series. 
A breath-hold, multiple-phase encoded, gradient echo se- 
quence with structured k-space sampling (14) was used in five 
sheep. A contiguous eries of multiphase, single-slice, 7-mm 
thick tagged images spanning the left ventricle from base to 
apex was performed. Imaging variables were interstripe dis- 
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Figure 1. A Sun workstation monitor loaded with the 
Volumetric Image Display and Analysis oftware. An 
end-systolic short-axis tagged spin echo image from a 
treated sheep 8 weeks after infarction (left). The 
markedly thinned infarcted septum (between the two 
large arrowheads) and the right ventricular apex ex- 
tend from the 6 o'clock to 9 o'clock positions on the 
image. The anterior wall extends from the 9 o'clock to 
12 o'clock positions on the image, the lateral wall from 
12 o'clock to 3 o'clock and the inferior wall from 3 
o'clock to 6 o'clock. An operator-drawn li e across 
three tags in the anterior wall is seen (small arrow). At 
the right is the graph depicting the signal intensity of 
the image crossed by the operator-drawn line. The 
signal nadirs representing the tags in the anterior wall 
are easily seen. Using nadir to nadir separations, 
measurement of interstripe separations in pixels or 
segment lengths is performed on end-diastolic (Le~) 
and end-systolic (Le~) frames. Percent circumferential 
shortening iscalculated as 100 (Led - Les)/Lea. ROI = 
region of interest. 
tance 7 ram, repetition time 8 ms, echo time 8 ms, 128 x 256 
matrix, and 28-cm field of view, yielding a final interpolated 
pixel size of 1.19 mm 2. Frame duration was 80 ms, and one 
frame was centered on end-systole. The breath hold was 
performed by holding the ventilator at end-expiration for 17 
heart beats, or -15 s/set of images obtained at the typical heart 
rate of the animals during the imaging session. 
Left ventricular mass and volume. Quantitative analysis of 
images was performed by an investigator in blinded manner 
using operator-driven image analysis tools (9,12,13) developed 
in the Volumetric Image Display and Analysis software pack- 
age (University of Iowa). Left ventricular mass and end- 
diastolic volume and the ratio of volume to mass were calcu- 
lated from planimetered endocardial and epicardial areas of 
interleaved short-axis, end-diastolic tagged images using pre- 
viously described methods (9). Stroke volume and ejection 
fraction were then calculated using end-diastolic and end- 
systolic volumes. All aforementioned values, except for the 
volume to mass ratio and ejection fraction, were normalized 
for body weight. 
Intramyocardiai segment shortening. To measure in- 
tramyocardial shortening, pairs of tag stripes oriented perpen- 
dicular to the endocardium were selected for analysis, by an 
operator in blinded manner using the Volumetric Image 
Display and Analysis software and previously published meth- 
ods (9,12,13) (Fig. 1). Percent shortening in the subendocar- 
dium and subepicardium at each time point was analyzed. 
Segmental function was analyzed over time using mean 
values for segments located within the infarcted, adjacent and 
remote regions as previously described (9). Infarcted regions 
were defined as clearly demarcated thinned wall segments in 
the studies performed at 8 weeks after myocardial infarction. 
Remote regions were selected as segments of the left ventricular 
wall located at least 2 cm from infarcted regions and typically 
included the two most basal slices imaged. Adjacent nonin- 
farcted regions were defined as those segments of normal 
thickness within 2 cm of the well defined infarct regions (Fig. 
2). Measurements from a mean of five tag stripe pairs of 
adjacent regions were averaged per data set from each animal. 
Because the infarct region includes the entire apex, func- 
tion in apical slices from the baseline images was compared 
with that in infarcted regions in the 8-week studies. Intramyo- 
cardial function in the two most basal slices on baseline images 
was compared with function in remote regions from the 8-week 
postinfarction studies. Right ventricular insertion sites and 
papillary muscles were used to match midventricular slices 
from the two time points and to correlate regions defined as 
adjacent in the postinfarction studies with the corresponding 
regions in the baseline study. 
Statistical analysis. Angiotensin-converting enzyme levels, 
mean systolic blood pressure, heart rate, pulmonary capillary 
wedge pressure, left ventricular mass, end-diastolic and end- 
systolic volumes, stroke volume, ejection fraction and percent 
circumferential shortening in the subendocardiurn a d subepi- 
cardium of each region were compared between groups at each 
time point by two-way repeated measures analysis of variance 
with Scheff6 subtesting where appropriate. To exclude differ- 
Figure 2. Analysis used to measure intramyocardial segmental func- 
tion on a regional basis. Adjacent regions were defined as those within 
2 em (in a three-dimensional sense) of clearly demarcated infarcted 
tissue, and remote regions were at least 2 cm beyond the infarct 
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Table 1. Clinical Variables and Measurements of Volumes, Mass and Ejection Fraction by Magnetic Resonance Imaging (mean ± SD) 
Control Group Treated Group 
Baseline 8 wk Change Baseline 8 wk Change 
PCWP (mm Hg) 6_+ 2 7-- 2 +1 _+ 2 6 + 4 7 + 2 +1 + 4 
EDV (ml/kg) 1.4 _+ 0.2 2.8 _+ 0.8 +1.5 _+ 0.7 1.6 + 0.6 2.1 _+ 0.6 +0.5 + 0.8* 
ESV (ml/kg) 0.8 _+ 0.2 2.3 _+ 0.9 +1.6 _+ 0.8 1.0 _+ 0.6 1.5 ± 0.6 -0.5 + 0.8I" 
SV (ml/kg) 0.6 _+ 0.1 0.5 _+ 0.2 -0.1 _+ 0.2 0.7 _+ 0.1 0.6 _- 0.1 -0.1 _+ 0.2 
EF (%) 47_+ 6 21 = 8 26 _+ 9 51 + 9% 28 _+ 10 -23 _+ 15 
Mass (g/kg) 2.2 _+ 0.4 2.6 _+ 0.4 +0.4 + 0.6 2.4 + 0.5 2.2 _+ 0.7 -0.2 _+ 0.6 
EDV/mass (ml/g) 0.7 _+ 0.3 1.1 _+ 0.3 +0.4 + 0.3 0.6 + 0.2 0.8 -- 0.2 +0.3 _+ 0.3 
*p < 0.04, tp < 0.05 versus control group. EDV = end-diastolic volume; EF - ejection fraction; ESV - end-systolic volume; PCWP = pulmonary, capilla~ wedge 
pressure; SV stroke volume. 
ences based on the imaging method used, we compared 
changes over time in percent circumferential shortening by 
imaging technique using two-way repeated measures analysis 
of variance. Regional wall thickness and infarct size at 8 weeks 
after infarction were compared between groups using the 
unpaired Student t test. 
Results 
Angiotensin-converting enzyme levels and determinants of 
load. Angiotensin-converting e zyme levels 2 days after infarc- 
tion were 61 _+ 12 U/liter (mean ± SD) in the control group 
and 59 ± 10 U/liter in the ramipril-treated group. Angiotensin- 
converting enzyme levels in the treated group decreased to 
<30% of control levels at 1 week after infarction (5 days after 
institution of ramipril therapy) and remained inhibited relative 
to control levels at 4 and 8 weeks after infarction (p < 0.0001). 
Weekly heart rates and mean blood pressures were not differ- 
ent between the control and treated groups throughout the 
course of the study. Mean pulmonary capillary wedge pressure 
measured under anesthesia did not change significantly in 
either group between the baseline magnetic resonance study 
and 8 weeks after infarction and was not different between 
groups (Table 1). 
Postmortem easurements. At 8 weeks after infarction in 
the postmortem hearts, the percent of left ventricular mass 
that was infarcted was not different between groups (14 _+ 4% 
in treated group, 17 ± 3% in control group, p = NS). No 
differences were found between the control and treated 
groups, respectively, inwall thickness in the infarct zone (4 ± 
1 vs. 5 ± 1 ram), adjacent noninfarcted region (12 _+ 2vs. 13 _+ 
3 ram) or remote noninfarcted region (14 ± 1 vs. 14 ± 2 mm). 
Left ventricular volumes and mass. Angiotensin-converting 
enzyme inhibitor therapy limited the increase in left ventricular 
end-diastolic volume over the 8-week time course (Table 1). 
End-diastolic volume increased by +1.5 + 0.7 ml/kg in the 
control group and by +0.5 ± 0.8 ml/kg in the treated group 
(p < 0.04). End-systolic volume increased by +1.6 + 
0.8 ml/kg in the control group and by only +0.5 _+ 0.8 ml/kg 
in the treated group (p < 0.05). Stroke volume decreased by 
1 ± 0.2 ml/kg in both groups. Stroke volume was preserved, 
but ejection fraction decreased after infarction in both 
groups (-26 _+ 9% in control animals, -23 + 15% in 
treated animals, p = NS). There was a trend toward lower 
mass during remodeling in the treated group, with an 
increase of +0.4 _+ 0.6 g/kg in the control group and a 
decrease of -0.2 _+ 0.6 g/kg in the treated group (p = 0.11). 
The volume/mass ratio increased in both groups (Table 1). 
Regional circumferential shortening. Function in in- 
farcted, adjacent and remote regions was not different at 
baseline between groups. At 8 weeks after infarction, percent 
subendocardial shortening in the apical infarcted tissue de- 
creased from 23 + 5% to 3 ± 5% in the control group and 
from 21 ± 7% to 6 -+ 5% in the treated group (p = NS) (Table 
2). Remote noninfarcted (basal) subendocardial function de- 
creased from 22 ± 5% to 17 _+ 3% in the control group and 
remained at 19 + 6% in the treated group (p = NS). In 
contrast, subendocardial percent circumferential shortening in
adjacent noninfarcted tissue decreased from 22 ± 5% to 9 ± 
2% in the control group and from 19 + 5% to 14 ± 5% in the 
treated group (p < 0.03) (Fig. 3). 
In the subepicardium, similar findings were observed. There 
were no significant differences between the two groups in the 
change in infarcted and remote regional function (Table 2). 
The decrease in percent subepicardial shortening in the adja- 
cent zone in the control group was greater than that in the 
angiotensin-converting e zyme inhibitor-treated group (from 
17 ± 5% to 4 _+ 4% vs. from 14 _+ 4% to 10 _+ 6%, p < 0.03). 
No differences in percent circumferential shortening be- 
tween the two imaging methods were found when the treated 
and untreated groups were combined. For example, when spin 
echo tagging was used, adjacent subendocardial percent short- 
ening decreased from 20 _+ 3% to 13 _+ 5%, whereas with 
gradient echo tagging, it decreased from 21 ± 7% to 13 -- 6%. 
Discuss ion  
Studies of the effect of angiotensin-converting e zyme 
inhibition on the heart after myocardial infarction have gen- 
erally concentrated on global changes in the left ventricular 
structure and function (17,18,22). Using magnetic resonance 
tissue tagging, we previously showed (9) that in the untreated 
left ventricle, segmental function is reduced in adjacent non- 
infarcted myocardium in the early postinfarction period and 
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Table 2. Subendocardial and Subepicardial Percent Circumferential Shortening inAll Regions 
(mean _+ SD) 
Control Group Ramipril Group 
Region Baseline 8 wk Change Baseline 8 wk Change 
Infarcted (%) 
Subendo 23 _+ 5 3 _+ 5 20 -- 10 21 _+ 7 6 + 5 -15 + 9 
Subepi 17_+ 4 2 +_ 5 15 _+ 8 17-+ 4 7_+ 6 -10 +_ 8 
Noninfarcted (%) 
Adjacent 
Subendo 22 +_ 5 9 _+ 2 -13 + 5 19 _+ 5 14 _+ 5 -5  -+ 5* 
Subepi 17 + 5 4_+ 4 13 + 5 14_+ 4 l0 + 6 3_+ 8* 
Remote 
Subendo 22 +- 5 17_+ 3 -5  _+ 6 19 ± 6 19 _+ 6 0-- 8 
Subepi 17 + 4 15 + 2 -2_+ 5 14 ± 3 15 _+ 7 +1 _+ 9 
*p < 0,03 versus control group. Subendo = subendocardial; Subepi = subepicardial. 
improves in part by 8 weeks after infarction but remains 
depressed relative to function in remote noninfarcted tissue. 
We suggested that these changes may reflect increased wall 
stress in adjacent regions and may be a stimulus to postinfarc- 
tion global ventricular remodeling. 
The present study demonstrates that angiotensin-converting 
enzyme inhibition attenuates the decline in adjacent noninfarcted 
regional intramural function in the first 8 weeks as the left 
ventricle remodels after a moderate-sized anterior infarction. No 
significant effect was found on segmental function in infarcted 
tissue or remote noninfarcted regions. In conjunction with its 
effect on regional function in adjacent noninfarcted tissue, 
angiotensin-converting e zyme inhibition limited the in- 
crease in left ventricular end-diastolic volume at 8 weeks 
after infarction in this model. We suggest hat adjacent 
region mechanical dysfunction due to elevated wall stress is 
an important determinant of remodeling and that angioten- 
sin-converting enzyme inhibition may alter the distribution 
of local wall stress in the infarcted left ventricle. 
Figure 3. Change in percent intramyocardial c rcumferential segment 
shortening in adjacent oninfarcted subendocardium from baseline to 
8 weeks after infarction i control and treated sheep. *p < 0.03 versus 
control animals by repeated measures analysis of variance. 
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Comparison with previous studies. The finding of a limi- 
tation of the increase in postinfarction end-diastolic volume 
with angiotensin-converting enzyme inhibition is consistent 
with previous tudies in animal models and humans (17,18,22). 
Angiotensin-converting enzyme inhibitors have also been 
shown to attenuate he increase in postinfarction left ventric- 
ular mass. Enalapril prevented the increase in left vcntricular 
mass seen in placebo-treated rats (24) and dogs (18,25) after 
myocardial necrosis. In the present study, ramipril tended to 
blunt the trend toward increased mass in the placebo group 
seen 8 weeks after infarction. 
Changes in global function after angiotensin-converting 
enzyme inhibition have been demonstrated in the canine 
model by Jugdutt et al. (17,18). They demonstrated reduced 
total eft ventricular asynergy, a qualitative index of contractile 
dysfunction, in captopril- and enalapril-treated animals com- 
pared with control animals. The variable of regional function 
measured in one of the studies (18) was regional ejection 
fraction at the midpapillary muscle level, a measure that can be 
altered by through-plane motion and one that depends on its 
anatomic relation to the infarct, which may be variable in the 
canine model. 
Potential mechanisms. Several potential explanations exist 
for the beneficial effect of angiotensin-converting enzyme 
inhibition on function in the noninfarcted adjacent region. A 
pure effect of load reduction is possible, although neither 
blood pressure nor filling pressures were different between 
groups in the present study. In a rat model of pressure 
overload hypertrophy by ascending aortic banding (26), fosi- 
nopril reduced cellular hypertrophy and improved systolic 
function without a change in systemic hemodynamic status. 
Reduced interstitial fibrosis in the adjacent noninfarcted re- 
gion could improve function, although we previously demon- 
strated little to no fibrosis in this region (9). Angiotensin- 
converting enzyme inhibition reduced interstitial fibrosis in 
noninfarcted regions and improved myocardial capillary den- 
sity while preventing hypertrophy in the rat model of infarction 
(24). 
Olivetti et al. (27) previously showed excess cellular hyper- 
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trophy in noninfarcted adjacent regions in the rat model. 
Angiotensin II induced cellular hypertrophy in cultured chick 
cardiomyocytes, and this hypertrophy was prevented by a 
specific angiotensin II antagonist (28). Reduction in hypertro- 
phy caused by angiotensin II may limit the decline in intramyo- 
cardial function in adjacent noninfarcted regions. 
Angiotensin-converting enzyme inhibition is associated 
with an increase in mechanical force of contraction. In one 
study (29), ramiprilat produced modest positive inotropy in 
isolated rat cardiac muscle strips and increased the responsive- 
ness of the muscle to the inotropic effects of bradykinin. 
Bradykinin release in cardiac tissue is increased by ramiprilat 
(30). McDonald et al. (31) demonstrated the bradykinin an- 
tagonism prevents the antiremodeling effect of ramipril. 
Study limitations. 1) Infarct size in the two groups was not 
assessed before randomization at postinfarction day 2. The 
infarct size as measured from the postmortem specimens at 8 
weeks after infarction was not different between the two 
groups, although angiotensin-converting enzyme inhibition 
may have differential effects on long-term changes in mass 
within infarcted and noninfarcted tissue. The anteroapical 
infarction created in the present model is very reproducible, as 
previously shown by our study group and others (9,23), with 
standard eviations of the infarct size of 4% and 3%, respec- 
tively. 2) The study was performed using two magnetic reso- 
nance tagging techniques, pin echo tagging and breath-hold 
gradient echo tagging. However, the techniques measure in- 
tramyocardial function in the same manner. In addition, each 
animal was studied at baseline and 8 weeks after infarction 
using the same technique. When compared quantitatively, no 
difference was found between measurements of region percent 
shortening made using the two methods. 
Conclusions. The present study demonstrates that angio- 
tensin-converting enzyme inhibition attenuates the decline in 
adjacent noninfarcted regional function in the first 8 weeks 
after anterior infarction in an ovine model. Angiotensin- 
converting enzyme inhibition limits the increase in left ventric- 
ular end-diastolic and end-systolic volume that occurs in 
untreated animals, without a change in blood pressure or left 
ventricular filling pressures. Adjacent noninfarcted regional 
dysfunction may contribute significantly to left ventricular 
remodeling after anterior infarction. By limiting adjacent 
regional dysfunction, angiotensin-converting e zyme inhibi- 
tion may attenuate one stimulus to global ventricular e- 
modeling. 
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